Results 211 to 220 of about 869,733 (343)

Antibody responses to SARS-CoV-2 in patients with COVID-19

Nature Network Boston, 2020
Quan-xin Long, Bai-Zhong Liu, H. Deng, Gui-cheng Wu, K. Deng, Yaokai Chen, P. Liao, Jing-Fu Qiu, Yong Lin, X. Cai, Deqiang Wang, Yuan Hu, Ji-hua Ren, N. Tang, Yin-yin Xu, Li-hua Yu, Z. Mo, Fang Gong, Xiao-li Zhang, Wen-guang Tian, Li Hu, Xian-xiang Zhang, Jiang-lin Xiang, Hong-xin Du, Hua-wen Liu, Chunhui Lang, Xiao-he Luo, Shao-bo Wu, X. Cui, Zheng Zhou, Manxiang Zhu, Jing Wang, Cheng-jun Xue, Xiao-feng Li, Li Wang, Zhi-jie Li, Kun Wang, Changchun Niu, Qing-jun Yang, Xiao-jun Tang, Yong Zhang, Xia-mao Liu, Jin-jing Li, De-chun Zhang, Fan Zhang, Ping Liu, Jun Yuan, Qin Li, Jie-Li Hu, Juan Chen, A. Huang   +50 more
semanticscholar   +1 more source

Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV. [PDF]

Sci Adv
Xu J, Chamblee M, Jiang F, Kc M, Hsu CC, Thongpan I, Chen P, Zhang Y, Chiu CT, Shamseldin MM, Amer HM, Liang X, Amer AO, Boyaka PN, Cormet-Boyaka E, Peeples ME, Li J.   +16 more
europepmc   +1 more source

Surgical Volume and Short‐Term Outcomes After Advanced Hepatectomy in the Postpandemic Era: Analysis of the Japanese National Clinical Database (2018–2023)

Annals of Gastroenterological Surgery, EarlyView.
This national survey using the National Clinical Database in Japan revealed a persistent decline in the number of advanced hepatectomies, even after the COVID‐19 pandemic. Despite this trend, surgical safety was effectively maintained in the postpandemic period using risk‐adjusted metrics.
Yusuke Takemura, Hideki Endo, Taizo Hibi, Ryo Seishima, Masashi Takeuchi, Hiroyuki Yamamoto, Hiromichi Maeda, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Ken Shirabe, Yuko Kitagawa   +13 more
wiley   +1 more source

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

, 2020
Thomas Mandel Clausen, Daniel R. Sandoval, Charlotte B. Spliid, Jessica Pihl, Chelsea D. Painter, Bryan E. Thacker, Charles A. Glass, Anoop Narayanan, Sydney A. Majowicz, Zhang Yang, Jonathan L. Torres, Gregory J. Golden, Ryan N. Porell, Aaron F. Garretson, Logan Laubach, Jared Feldman, Xin Yin, Yuan Pu, Blake M. Hauser, Timothy M. Caradonna, Benjamin P. Kellman, Cameron Martino, Philip L.S.M. Gordts, Sandra L. Leibel, Summit K. Chanda, Aaron G. Schmidt, Kamil Godula, Joyce Jose, Kevin D. Corbett, Andrew B. Ward, Aaron F. Carlin, Jeffrey D. Esko   +31 more
openalex   +1 more source

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic. [PDF]

BMC Infect Dis
Dave N, van der Werff SD, Sjöholm D, Zetterqvist J, Nauclér P.   +4 more
europepmc   +1 more source

Tau Amyloid Corona‐Shelled Nanoparticle‐Based Drug Screening Platform for Discovering Tau Oligomer‐Degrading Drugs

Aggregate, EarlyView.
Tau amyloid corona‐shelled nanoparticles (TACONs) were synthesized by incubating gold nanoparticles (AuNPs) with tau monomers that had been pre‐reacted with heparin. These TACONs represent a promising high‐throughput screening platform for identifying tau oligomer degraders as potential therapeutic agents for Alzheimer's disease.
Hyo Gi Jung, Dongsung Park, Junho Bang, Yeon Ho Kim, Jae Won Jang, Yonghwan Kim, Hyunji Kim, Seungmin Lee, Wonbin Moon, Kyo Seon Hwang, Jeong Hoon Lee, Dongtak Lee, Dae Sung Yoon   +12 more
wiley   +1 more source

Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment

, 2020
Shuntong Kang, Wenyao Peng, Yuhao Zhu, Shi Yao Lu, Min Zhou, Wei Lin, Wenfang Wu, Shu Huang, Liping Jiang, Xuan Luo, Meichun Deng   +10 more
openalex   +1 more source

SARS-CoV-2 neuroinvasion [PDF]

Nature Immunology, 2020
openaire   +3 more sources

The Effect of SARS-CoV-2 Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE). [PDF]

Clin Infect Dis
Openshaw JJ, Chen J, Rodriguez R, Gottlieb M, McCullough K, Santangelo M, Hill MJ, Gatling K, Idris AH, Idris AH, McDonald S, Wisk LE, Dyal J, Wang RC, Rising KL, Kean E, O'Laughlin KN, Stephens KA, Malicki C, Lin Z, Spatz ES, Yu H, Weinstein RA, Elmore J.   +23 more
europepmc   +1 more source

Intelligent Theranostic Systems Enabled by Aggregation‐Induced Emission in Precision Medicine

Aggregate, EarlyView.
Aggregation‐induced emission (AIE) luminogens are driving a new generation of intelligent theranostic systems that integrate high‐fidelity imaging and multifunctional therapy. This review highlights how AIEgens, through restriction of intramolecular motion (RIM), enable deep‐tissue NIR‐II imaging, ultrasensitive biosensing, CRISPR‐assisted gene ...
Qinqin Huang, Yanyu Chen, Shile Wang, Kan Liu, Xing‐Zhong Zhao, Xiaobo Mao, Ben Zhong Tang, Lang Rao   +7 more
wiley   +1 more source